Back to Search Start Over

A MEPS-UHPLC-MS/MS analytical platform to detect isoprostanoids and specialized pro-resolving mediators in the urinary extracellular vesicles of mountain ultramarathon runners.

Authors :
Biagini D
Mrakic-Sposta S
Bondi D
Ghimenti S
Lenzi A
Vivaldi F
Santangelo C
Verratti V
Pietrangelo T
Vezzoli A
Giardini G
Oger C
Galano JM
Balas L
Durand T
D'Angelo G
Lomonaco T
Di Francesco F
Source :
Talanta [Talanta] 2024 Nov 01; Vol. 279, pp. 126619. Date of Electronic Publication: 2024 Jul 25.
Publication Year :
2024

Abstract

Oxylipins are powerful signalling compounds derived from polyunsaturated fatty acids (PUFAs) and involved in regulating the immune system response. A mass spectrometry-based method was developed and validated for the targeted profiling of 52 oxylipins (e.g., isoprostanoids, prostaglandins, epoxy- and hydroxy-fatty acids, specialized pro-resolving mediators) and 4 PUFAs in small urinary extracellular vesicles (uEVs). Ultrasound-assisted extraction using a 50:50 v/v MeOH:H <subscript>2</subscript> O mixture ensured optimal analytical performances. Limits of detection ranged between 10 and 400 pg/mL for oxylipins and 0.10-3 ng/mL for PUFAs. Satisfactory recoveries (85-116 %) and good intra- and inter-day precisions (RSD ≤15 %) were obtained for all the analytes. The reliability of the procedure was tested in a real case scenario by monitoring ultramarathon runners during the world Tor des Géants® (TDG) race. Both F <subscript>2</subscript> - and E <subscript>2</subscript> -isoprostanes were detected in small uEVs of the ultramarathon runners, suggesting the onset of an oxidant insult. 5-F <subscript>2t</subscript> -IsoP exhibited significant pre- to post-race variations, thus potentially representing a non-invasive marker of in-vivo lipid peroxidation. The presence of specialized pro-resolving mediators suggests the activation of pro-resolution signalling cascade resolving inflammation. These outcomes may help manage post-exercise recovery and improve training.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024. Published by Elsevier B.V.)

Details

Language :
English
ISSN :
1873-3573
Volume :
279
Database :
MEDLINE
Journal :
Talanta
Publication Type :
Academic Journal
Accession number :
39067203
Full Text :
https://doi.org/10.1016/j.talanta.2024.126619